Clinical Trials on Docetaxel

Total 12 results

Zhuhai Beihai Biotech Co., Ltd

Completed

A Bioequivalence Study of Docetaxel Injection in Patients With Solid Tumours

Solid Tumours | Bioequivalence | Docetaxel

India
University of Turku
Turku University Hospital; Sanofi; Vaasa Central Hospital, Vaasa, Finland; medbase...

Completed

Study of Usefulness of Genotyping to Predict Docetaxel Exposure and Adverse Events (Docetaxel)

CYP3A Phenotyping | CYP3A5 and MDR1 Genotyping | Docetaxel Toxicity | Associations Between Genetic Data and Docetaxel Toxicity

Finland
Cui Yimin

Unknown

Association of Genetic Polymorphisms With Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor Patients

Pharmacokinetics | Drug-Related Side Effects and Adverse Reactions | Solid Tumors | Pharmacogenetics | Docetaxel

China
Samsung Medical Center

Completed

A Trial of Evonail® Solution for Prevention or Treatment of Onycholysis

Breast Cancer | Docetaxel Chemotherapy

Korea, Republic of
Sixth Affiliated Hospital, Sun Yat-sen University

Unknown

Dose-dense Biweekly Docetaxel, Oxaliplatin and 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer (DaeMon-Plus)

Docetaxel, Oxaliplatin and Fluorouracil

China
Centro Nacional de Investigaciones Oncologicas...

Unknown

PROSTAC: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Docetaxel or Cabazitaxel. (PROSTAC)

Advanced Prostate Cancer | Docetaxel | Cabazitaxel

Spain
Hongqian Guo

Active, not recruiting

Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer

Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel

China
The First People's Hospital of Lianyungang
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer

Lung Neoplasms | Anlotinib | Docetaxel | S-1 | Pemetrexed

China
Centre Hospitalier Universitaire de Besancon

Completed

Interest of the Addition of Docetaxel to Standard Treatment in First-line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients (TandHER)

Metastatic Cancer | HER2-positive Gastric Cancer | Docetaxel | Trastuzumab

France
Peking University Cancer Hospital & Institute

Unknown

A Study of Nivolumab +/- Docetaxel in Patients Previously Treated With Advanced or Metastatic NSCLC

Carcinoma, Non-Small-Cell Lung | Docetaxel | Nivolumab

China
Blokhin's Russian Cancer Research Center

Recruiting

FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma (RusGCG-01)

Stomach Neoplasms | Gastrointestinal Neoplasms | Docetaxel | Oxaliplatin | Fluoruracil | Irinotecan Hydrochloride

Russian Federation
Dokuz Eylul University

Not yet recruiting

Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients

Bladder Cancer | Gemcitabine | BCG | Docetaxel | Intravesical Instillation

Turkey

Clinical Trials on Docetaxel

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations